• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Selection of Surrogate Marker Genes in Malignant Brain Tumor to Advanced Therapy by DNA Array Analysis of Gene Expression Profiles

Research Project

Project/Area Number 14370428
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Cerebral neurosurgery
Research InstitutionNiigata University

Principal Investigator

YAMANAKA Ryuya  Niigata University, Brain Research Institute, Lecturer, 脳研究所, 講師 (20323991)

Co-Investigator(Kenkyū-buntansha) TANAKA Ryuichi  Niigata University, Brain Research Institute, Professor, 脳研究所, 教授 (30018816)
TAKAHASHI Hideaki  Niigata University, Medical and Dental Hospital, Lecturer, 医歯学総合病院, 講師 (70236305)
Project Period (FY) 2002 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥10,700,000 (Direct Cost: ¥10,700,000)
Fiscal Year 2004: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2003: ¥2,000,000 (Direct Cost: ¥2,000,000)
Fiscal Year 2002: ¥7,800,000 (Direct Cost: ¥7,800,000)
Keywordsmalignant brain tumor / Gene expression profile / Gene Chip / Immunotherapy / Chemotherapy / Thermotherapy / Gene Chip
Research Abstract

Glioblastoma, anaplastic glioma(Grade III), low grade glioma, primary central nervous
system lymphoma and normal brain samples were studied (total of 100 samples) using cDNA microarray technology. The phylogenetic tree resulting from the hierarchical clustering algorithm have employed. Fifty genes were selected as specific molecular targeted genes in glioblastoma and primary central nervous system lymphoma.
In conclusion, accumulation of data with respect to expression profiles of malignant brain tumor specimens, clinico-pathological data, susceptibility to treatment, and outcome will bring us information for identifying optimized therapeutic modalities for individual patients and novel therapeutic targets.

Report

(4 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • 2002 Annual Research Report
  • Research Products

    (29 results)

All 2004 2003 2002 Other

All Journal Article (18 results) Book (1 results) Patent(Industrial Property Rights) (1 results) Publications (9 results)

  • [Journal Article] Development of improved Sindbis virus-based DNA expression vector2004

    • Author(s)
      Yamanaka R
    • Journal Title

      DNA Cell Biol 23

      Pages: 75-80

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Development of improved Sindbis virus-based DNA expression vector2004

    • Author(s)
      Yamanaka R
    • Journal Title

      DNA Cell Biol vol.23

      Pages: 75-80

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Development of improved Sindbis virus-based DNA expression vector2004

    • Author(s)
      Yamanaka R
    • Journal Title

      DNA Cell Biol 23(2)

      Pages: 75-80

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Alpha Virus Vectors for Cancer Gene Therapy (Review).2004

    • Author(s)
      Yamanaka R
    • Journal Title

      Int J Oncol 24(4)

      Pages: 919-923

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Advances for the treatment of primary central nervous system lymphoma (Review).2004

    • Author(s)
      Yamanaka R
    • Journal Title

      Oncol Rep 12

      Pages: 563-568

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Gene Therapy of Brain Tumor with Endostatin2004

    • Author(s)
      Yamanaka R
    • Journal Title

      Drug of Today 40(11)

      Pages: 931-934

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses : results of a clinical phase I/II trial2003

    • Author(s)
      Yamanaka R
    • Journal Title

      Br J Cancer 89

      Pages: 1172-1179

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Selection of surrogate marker genes in primary central nervous system lymphomas to radio-chemotherapy by DNA array analysis of gene expression profiles2003

    • Author(s)
      Yamanaka R
    • Journal Title

      Int J Oncol 23

      Pages: 913-923

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Vaccination of recurrent glioma patients with tumor lysate-pulsed dendritic cells elicits immune responses : results of a clinical phase I/II trial2003

    • Author(s)
      Yamanaka R
    • Journal Title

      Br J Cancer vol.89

      Pages: 1172-1179

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Selection of surrogate marker genes in primary central nervous system lymphomas to radio-chemotherapy by DNA array analysis of gene expression profiles2002

    • Author(s)
      Yamanaka R
    • Journal Title

      Int J Oncol vol.23

      Pages: 561-561

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Immunological evaluation of personalized peptide vaccination for patients with advanced malignant glioma

    • Author(s)
      Yajima N
    • Journal Title

      Clinical Cancer Research (In press)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma ; Results of a Clinical Phase I/II Trial

    • Author(s)
      Yamanaka R
    • Journal Title

      Clinical Cancer Research (in press)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Modified ProMACE-MOPP Hybrid Regimen with moderate dose methotrexate for Patients with Primary CNS Lymphoma

    • Author(s)
      Yamanaka R
    • Journal Title

      Ann Hematol (in press)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Immunological evaluation of personalized peptide Vaccination for patients with advanced malignant glioma

    • Author(s)
      Yajima N
    • Journal Title

      Clinical Cancer Research (in press)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma : Results of a Clinical Phase I/II Trial

    • Author(s)
      Yamanaka R
    • Journal Title

      Clinical Cancer Research (in press)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Modified ProMACE-MOPP Hybrid Regimen with moderate dose methotrexate for Patients with Primary CNS Lymphoma

    • Author(s)
      Yamanaka R
    • Journal Title

      Ann Hematol (in press)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malign

    • Author(s)
      Yamanaka R
    • Journal Title

      J Neuro-oncol (In press)

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Modified ProMACE-MOPP Hybrid Regimen with moderate dose methotrexate for Patients with Primary CNS Lymphoma

    • Author(s)
      Yamanaka R
    • Journal Title

      Ann.Hematol. (In press)

    • Related Report
      2004 Annual Research Report
  • [Book] ポストシークエンス時代における脳腫瘍の研究と治療2002

    • Author(s)
      山中龍也
    • Total Pages
      561
    • Publisher
      九州大学出版会
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Patent(Industrial Property Rights)] 脳腫瘍の検出方法及びそれに用いる脳腫瘍の検出物質2004

    • Inventor(s)
      土屋 尚人, 山中 龍也, 池中 一裕
    • Industrial Property Rights Holder
      土屋 尚人, 山中 龍也, 池中 一裕
    • Industrial Property Number
      2004-247849
    • Filing Date
      2004-08-27
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Publications] Soga Y: "CCAAT/enhancer binding proteins are expressed in the gerbil hippocampus after transient forebrain ischemia"Neurosci Lett. 337・2. 106-110 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yamanaka R: "Dendritic cell-based glioma immunotherapy (Review)"Int J Oncol.. 23・1. 5-15 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Kobayashi T: "Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8(+) cytotoxic T cells in patients with malignant glioma"Cancer Immunol Immunother. 52. 632-637 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yamanaka R: "Selection of surrogate marker genes in primary central nervous system lymphomas to radio-chemotherapy by DNA array analysis of gene expresssion profiles"Int J Oncol. 23・4. 913-923 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yamanaka R: "Induction of an antitumor immunological response by an intratumoral injection of dendritiic cells pulsed with genetically engineered Semliki Forest virus to produce interleukine-18 combined with systemic administration of interleukin-12"J Neurosurg. 99. 746-753 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 山中龍也: "悪性神経謬腫に対する樹状細胞療法(総説)"脳と神経. 55・9. 771-780 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yamanaka R: "Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12"J Neurosurg. 97. 611-618 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Yamanaka R: "Administration of interleukin-12 and -18 enhancing the antitumor immunity of genetically modified dendritic cells that had been pulsed with Semliki forest virus-mediated tumor complementary DNA"J Neurosurg. 97. 1184-1190 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 山中龍也: "悪性脳腫瘍症例の治療感受性を規定する遺伝子発現プロファイル解析、ポストシークエンス時代の研究、ポストシークエンス時代における脳腫瘍の研究と治療"田淵和雄, 白石哲也監修, 九州大学出版会. 91-95 (2002)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi